Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Most popular
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT) Gilead Sciences, Inc (NASDAQ:GILD) Clovis Oncology, Inc. (NASDAQ:CLVS) ...

David Rich - April 11, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right Now

Portola Pharmaceuticals Inc (NASDAQ:PTLA): A Misinterpretation Discount?

Teva Pharmaceutical Industries (NYSE:TEVA) Executive Yitzhak Peterburg Claims Health Care Industry Facing Disruption

Weekly Biotech Report – Covering Clovis Oncology Inc (NASDAQ:CLVS) Chiasma Inc (NASDAQ:CHMA) Sarepta Therapeutics Inc (NASDAQ:SRPT) Collegium Pharmaceutical Inc. (NASDAQ:COLL)

biotech

INSYS is Targeting a $700 Million Market With Syndros

Jennifer Aldershot - November 30, 2015 0
recovery

Why The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity

- September 14, 2016 0
AstraZeneca plc (ADR) (NYSE:AZN)

Weekly Biotech Report Part I – FDA To Decide On AstraZeneca...

David Rich - May 16, 2016 0
biomarin

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0
VBLT logo

VBL Therapeutics CEO tells us about their revolutionary approach to cure...

David Rich - September 16, 2016 0
biotech

Biotech and Opko Health, Inc. (NYSE:OPK) May Be Set For a...

Roger Hannington - February 22, 2016 0

Weekly Biotech Review Part I, Covering Titan Pharmaceuticals, Inc. (NASDAQ:TTNP)

David Rich - May 23, 2016 0

Why FDA Delay on Brodalumab Is Actually Great News For Valeant...

David Rich - November 29, 2016 0
novo

The How, What and When of Semaglutide

ME Staff - July 13, 2015 0

Is Pain Therapeutics, Inc. (NASDAQ:PTIE) And Remoxy’s Long And Winding Road...

- July 4, 2016 1
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019